The clinical utility of PD-L1 testing in selecting non-small cell lung cancer patients for PD1/PD-L1 directed therapy

Ítems similars

• PD-L1 Testing in Guiding Patient Selection for PD-1/PD-L1 Inhibitor Therapy in Lung Cancer
  per: Hunter, Katerina Ancevski, et al.
  Publicat: (2018)
• Personalized Therapy for Non-Small Cell Lung Cancer: Which Drug for Which Patient?
  per: Villaruz, Liza C., et al.
  Publicat: (2011)
• The Role of Anti-angiogenesis in Non-small-cell Lung Cancer: an Update
  per: Villaruz, Liza C., et al.
  Publicat: (2015)
• Personalizing Therapy in Advanced Non–Small Cell Lung Cancer
  per: Villaruz, Liza C., et al.
  Publicat: (2013)
• Management of Non-Small Cell Lung Cancer with Oligometastasis
  per: Villaruz, Liza C., et al.
  Publicat: (2012)